Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

13.70
+0.28002.09%
Post-market: 13.700.00000.00%16:27 EDT
Volume:1.66M
Turnover:22.69M
Market Cap:1.18B
PE:-3.68
High:13.98
Open:13.45
Low:13.25
Close:13.42
Loading ...
Sep 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 07, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
May 04, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Apr 30, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Mar 05, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, item 5.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 1.01 and 2.03
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals